{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T03:28:46Z","timestamp":1784172526171,"version":"3.55.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":24,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["j intensive care"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Sedation is essential in intensive care units (ICUs) for invasive procedures and mechanical ventilation; however, commonly used agents are limited by hemodynamic instability, delayed recovery of consciousness, and delirium. Remimazolam, an ultra-short-acting benzodiazepine, introduced in 2020, is rapid metabolized by hepatic carboxylesterase 1 and enables predictable recovery after prolonged administration, suggesting potential advantages for sedation in critical illness despite limited ICU-specific evidence. A narrative review was conducted based on evidence derived from randomized controlled trials, meta-analyses, and observational studies, which indicated that remimazolam provides sedation efficacy comparable to that of conventional hypnotics across surgical anesthesia, procedural sedation, and ICU settings. Multiple meta-analyses have suggested that remimazolam is associated with favorable hemodynamic tolerance and does not increase the incidence of postoperative or ICU delirium compared with propofol or other sedative agents. Delirium risk appears to be more strongly influenced by patient severity, surgical characteristics, and sedation depth than by hypnotic choice alone, although the heterogeneity across studies may partly reflect differences in delirium diagnostic tools. In ICU patients requiring mechanical ventilation, remimazolam demonstrated safety and efficacy comparable to those of propofol or midazolam, with acceptable hemodynamic stability and no consistent signs of increased mortality. Several studies have also suggested that the predictable recovery profile associated with flumazenil may facilitate ventilator weaning or recovery of consciousness, although the interpretation of recovery outcomes requires caution, particularly in studies involving routine flumazenil administration. Pharmacokinetic data in ICU populations remain limited but suggest preserved dose linearity with reduced clearance in patients with severe hepatic dysfunction. Remimazolam may be a promising sedative option for critically ill patients, offering a predictable recovery and generally favorable hemodynamic profiles. However, its optimal role in ICU sedation requires confirmation through high-quality international multicenter studies, particularly regarding prolonged mechanical ventilation, neurocognitive outcomes, and cost-effectiveness.<\/jats:p>","DOI":"10.1186\/s40560-026-00857-8","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T08:34:25Z","timestamp":1769157265000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Safety and efficacy of remimazolam in critical illness"],"prefix":"10.1186","volume":"14","author":[{"given":"Shinju","family":"Obara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoki","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,23]]},"reference":[{"key":"857_CR1","volume":"7","author":"K Heybati","year":"2025","unstructured":"Heybati K, Xie G, Deng J, Walkey AJ, Gajic O, Yadav H. Hemodynamic Effects of Guideline-Based Sedation in Mechanically Ventilated Adults: A Multicenter Observational Analysis. Crit care explor. 2025;7:e1313.","journal-title":"Crit care explor"},{"key":"857_CR2","volume":"1","author":"K Chen","year":"2015","unstructured":"Chen K, Lu Z, Xin YC, Cai Y, Chen Y, Pan SM. Alpha-2 agonists for long-term sedation during mechanical ventilation in critically ill patients. Cochrane Database Syst Rev. 2015;1:Cd010269.","journal-title":"Cochrane Database Syst Rev"},{"key":"857_CR3","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1056\/NEJMoa1904710","volume":"380","author":"Y Shehabi","year":"2019","unstructured":"Shehabi Y, Howe BD, Bellomo R, Arabi YM, Bailey M, Bass FE, et al. Early Sedation with Dexmedetomidine in Critically Ill Patients. N Engl J Med. 2019;380:2506\u201317.","journal-title":"N Engl J Med"},{"key":"857_CR4","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1111\/bcp.16031","volume":"90","author":"TG van Gelder","year":"2024","unstructured":"van Gelder TG, van Diem-Zaal IJ, Dijkstra-Kersten SMA, de Mul N, Lalmohamed A, Slooter AJC. The risk of delirium after sedation with propofol or midazolam in intensive care unit patients. Br J Clin Pharmacol. 2024;90:1471\u20139.","journal-title":"Br J Clin Pharmacol"},{"key":"857_CR5","doi-asserted-by":"publisher","first-page":"e825","DOI":"10.1097\/CCM.0000000000003299","volume":"46","author":"JW Devlin","year":"2018","unstructured":"Devlin JW, Skrobik Y, G\u00e9linas C, Needham DM, Slooter AJC, Pandharipande PP, et al. Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation\/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU. Crit Care Med. 2018;46:e825\u201373.","journal-title":"Crit Care Med"},{"key":"857_CR6","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1213\/ANE.0000000000007481","volume":"141","author":"S Obara","year":"2025","unstructured":"Obara S, Brandenburg J. Bridging the Gap: Clinical Application of Remimazolam Across Borders. Anesth Analg. 2025;141:86\u20139.","journal-title":"Anesth Analg"},{"key":"857_CR7","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.bja.2021.05.027","volume":"127","author":"T St\u00f6hr","year":"2021","unstructured":"St\u00f6hr T, Colin PJ, Ossig J, Pesic M, Borkett K, Winkle P, et al. Pharmacokinetic properties of remimazolam in subjects with hepatic or renal impairment. Br J Anaesth. 2021;127:415\u201323.","journal-title":"Br J Anaesth"},{"key":"857_CR8","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1186\/s12871-024-02773-6","volume":"24","author":"H Zhang","year":"2024","unstructured":"Zhang H, Fu M, Yue F, Wei Y, Shi X, Yu S, et al. Comparison of the anesthetic effects of remimazolam tosilate and remimazolam besylate in daytime hysteroscopic surgery. BMC Anesthesiol. 2024;24:382.","journal-title":"BMC Anesthesiol"},{"key":"857_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13247791","author":"JL Mu\u00f1oz-Carrillo","year":"2024","unstructured":"Mu\u00f1oz-Carrillo JL, Rodr\u00edguez-Cortes N, L\u00e9vano ST, Moran-Mari\u00f1os C, Barboza JJ. Remimazolam versus propofol in general anesthesia of complex surgery in critical and non-critical patients: meta-analysis of randomized trials. J Clin Med. 2024. https:\/\/doi.org\/10.3390\/jcm13247791.","journal-title":"J Clin Med"},{"key":"857_CR10","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s40520-025-03166-6","volume":"37","author":"RJ Tong","year":"2025","unstructured":"Tong RJ, Lv YZ, Shi YF, Lai L, Shen QH. Remimazolam versus propofol for postoperative delirium prevention in geriatric surgery: A systematic review and meta-analysis of randomized controlled trials. Aging Clin Exp Res. 2025;37:253.","journal-title":"Aging Clin Exp Res"},{"key":"857_CR11","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s12871-025-03018-w","volume":"25","author":"C Li","year":"2025","unstructured":"Li C, Wei L, Gong H, Yuan X. Incidence and predictors of postoperative delirium following remimazolam administration: a systematic review and meta-analysis of 29 randomized trials. BMC anesthesiol. 2025;25:201.","journal-title":"BMC anesthesiol"},{"key":"857_CR12","doi-asserted-by":"publisher","first-page":"383","DOI":"10.17305\/bb.2025.12826","volume":"26","author":"H Zhou","year":"2025","unstructured":"Zhou H, Zhang J, Du C. Remimazolam vs propofol for postoperative delirium in adults undergoing general anesthesia: A meta-analysis. Biomol Biomed. 2025;26:383\u201398.","journal-title":"Biomol Biomed"},{"key":"857_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinane.2024.111735","volume":"101","author":"M Suga","year":"2025","unstructured":"Suga M, Yasuhara J, Watanabe A, Takagi H, Kuno T, Nishimura T, et al. Postoperative delirium under general anaesthesia by remimazolam versus propofol: a systematic review and meta-analysis of randomised controlled trials. J Clin Anesth. 2025;101:111735.","journal-title":"J Clin Anesth"},{"key":"857_CR14","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1097\/EJA.0000000000002107","volume":"42","author":"JA Arias","year":"2025","unstructured":"Arias JA, Wegner GRM, Wegner BFM, Silva LS, Bezerra FJL, Filardi RGM. Association of remimazolam with delirium and cognitive function: a systematic review and meta-analysis of randomised controlled trials. Eur J Anaesthesiol. 2025;42:285\u201397.","journal-title":"Eur J Anaesthesiol"},{"key":"857_CR15","doi-asserted-by":"publisher","first-page":"7005","DOI":"10.2147\/DDDT.S531551","volume":"19","author":"Z Zhu","year":"2025","unstructured":"Zhu Z, Yang G, Chu Q, Cheng M, Li Z, Zang L, et al. Impact of remimazolam on postoperative delirium in elderly non-cardiac surgery patients admitted to the ICU: a retrospective propensity score matched study. Drug Des Devel Ther. 2025;19:7005\u201314.","journal-title":"Drug Des Devel Ther"},{"key":"857_CR16","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00540-022-03119-7","volume":"37","author":"Y Aoki","year":"2023","unstructured":"Aoki Y, Kurita T, Nakajima M, Imai R, Suzuki Y, Makino H, et al. Association between remimazolam and postoperative delirium in older adults undergoing elective cardiovascular surgery: a prospective cohort study. J Anesth. 2023;37:13\u201322.","journal-title":"J Anesth"},{"key":"857_CR17","volume":"17","author":"A Miyazaki","year":"2025","unstructured":"Miyazaki A, Hokka M, Mizobuchi S. Comparison of the effects of remimazolam and sevoflurane on intraoperative hemodynamics in patients undergoing off-pump coronary artery bypass surgery: a retrospective observational study. Cureus. 2025;17:e82338.","journal-title":"Cureus"},{"key":"857_CR18","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s12630-024-02900-4","volume":"72","author":"S Harimochi","year":"2025","unstructured":"Harimochi S, Godai K, Nakahara M, Matsunaga A. Comparison of remimazolam and sevoflurane for general anesthesia during transcatheter aortic valve implantation: a randomized trial. Can J Anaesth. 2025;72:397\u2013408.","journal-title":"Can J Anaesth"},{"key":"857_CR19","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.bja.2024.05.008","volume":"133","author":"X-Q Deng","year":"2024","unstructured":"Deng X-Q, Yu H, Wang W-J, Wu Q-L, Wei H, Deng J-S, et al. Effect of volatile versus propofol anaesthesia on major complications and mortality after cardiac surgery: a multicentre randomised trial. Br J Anaesth. 2024;133:296\u2013304.","journal-title":"Br J Anaesth"},{"key":"857_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-43895-0","volume":"13","author":"A Kitaura","year":"2023","unstructured":"Kitaura A, Tsukimoto S, Sakamoto H, Hamasaki S, Nakao S, Nakajima Y. A retrospective comparative study of anesthesia with remimazolam and remifentanil versus dexmedetomidine and remifentanil for transcatheter aortic valve replacement. Sci Rep. 2023;13:17074.","journal-title":"Sci Rep"},{"key":"857_CR21","doi-asserted-by":"publisher","first-page":"537","DOI":"10.4097\/kja.24138","volume":"77","author":"JH Kim","year":"2024","unstructured":"Kim JH, Nam JS, Seo WW, Joung KW, Chin JH, Kim WJ, et al. Effects of remimazolam versus dexmedetomidine on recovery after transcatheter aortic valve replacement under monitored anesthesia care: a propensity score-matched, non-inferiority study. Korean J Anesthesiol. 2024;77:537\u201345.","journal-title":"Korean J Anesthesiol"},{"key":"857_CR22","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1097\/CM9.0000000000002243","volume":"135","author":"Y Tang","year":"2022","unstructured":"Tang Y, Yang X, Shu H, Yu Y, Xu J, Pan S, et al. Remimazolam besylate for sedation of postoperative patients in intensive care units: a phase I, open label, dose-finding study. Chin Med J (Engl). 2022;135:2134\u20136.","journal-title":"Chin Med J (Engl)"},{"key":"857_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-20946-6","volume":"12","author":"X Chen","year":"2022","unstructured":"Chen X, Zhang J, Yuan S, Huang H. Remimazolam besylate for the sedation of postoperative patients undergoing invasive mechanical ventilation in the ICU: a prospective dose\u2012response study. Sci Rep. 2022;12:19022.","journal-title":"Sci Rep"},{"key":"857_CR24","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1186\/s13054-023-04760-8","volume":"27","author":"Y Tang","year":"2023","unstructured":"Tang Y, Gao X, Xu J, Ren L, Qi H, Li R, et al. Remimazolam besylate versus propofol for deep sedation in critically ill patients: a randomized pilot study. Crit Care. 2023;27:474.","journal-title":"Crit Care"},{"key":"857_CR25","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s13054-022-04168-w","volume":"26","author":"Y Tang","year":"2022","unstructured":"Tang Y, Yang X, Yu Y, Shu H, Yuan Y, Liu H, et al. Remimazolam besylate versus propofol for long-term sedation during invasive mechanical ventilation: a pilot study. Crit Care. 2022;26:279.","journal-title":"Crit Care"},{"key":"857_CR26","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1186\/s40001-023-01440-9","volume":"28","author":"Z Yao","year":"2023","unstructured":"Yao Z, Liao Z, Li G, Wang L, Zhan L, Xia W. Remimazolam tosylate\u2019s long-term sedative properties in ICU patients on mechanical ventilation: effectiveness and safety. Eur J Med Res. 2023;28:452.","journal-title":"Eur J Med Res"},{"key":"857_CR27","doi-asserted-by":"publisher","DOI":"10.21037\/jeccm-24-123","author":"S Turi","year":"2025","unstructured":"Turi S, Belletti A, Marmiere M, Faustini C, Campugiani A, D\u2019Amico F, et al. Feasibility of remimazolam use for sedation in critically ill patients with respiratory failure: a case series. J Emerg Crit Care Med. 2025. https:\/\/doi.org\/10.21037\/jeccm-24-123.","journal-title":"J Emerg Crit Care Med"},{"key":"857_CR28","doi-asserted-by":"publisher","first-page":"31","DOI":"10.5847\/wjem.j.1920-8642.2023.020","volume":"14","author":"YR Zhao","year":"2023","unstructured":"Zhao YR, Huang KS, Hou G, Yao L, Lu LP, Xu S, et al. Efficacy and safety of remimazolam-based sedation for intensive care unit patients undergoing upper gastrointestinal endoscopy: a cohort study. World J Emerg Med. 2023;14:31\u20136.","journal-title":"World J Emerg Med"},{"key":"857_CR29","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13613-025-01431-5","volume":"15","author":"Y Tian","year":"2025","unstructured":"Tian Y, Li J, Jin M, Piao Y, Sheng J, Mei Z, et al. Procedural sedative effect of remimazolam in ICU patients on invasive mechanical ventilation: a randomised, prospective study. Ann Intensive Care. 2025;15:8.","journal-title":"Ann Intensive Care"},{"key":"857_CR30","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12871-025-02903-8","volume":"25","author":"Y Li","year":"2025","unstructured":"Li Y, Yuan Y, Zhou J, Ma L. Effect of remimazolam besylate on elderly patients with mechanical ventilation: a single-center randomized controlled study. BMC Anesthesiol. 2025;25:65.","journal-title":"BMC Anesthesiol"},{"key":"857_CR31","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1186\/s12871-025-03167-y","volume":"25","author":"A Li","year":"2025","unstructured":"Li A, Zhou Y, Wu L, Hu B. The effects of remimazolam and propofol on delirium following anesthesia and sedation in elderly patients: a systematic review and meta-analysis. BMC Anesthesiol. 2025;25:312.","journal-title":"BMC Anesthesiol"},{"key":"857_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1553495","volume":"12","author":"R Liu","year":"2025","unstructured":"Liu R, Su B, Gan G, Wang G, Wang C, Xu N, et al. Effect of remimazolam besylate versus midazolam on time to extubation in critically ill, mechanically ventilated patients: a randomized controlled trial. Front Med. 2025;12:1553495.","journal-title":"Front Med"},{"key":"857_CR33","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1007\/s00134-020-06307-9","volume":"46","author":"G Chanques","year":"2020","unstructured":"Chanques G, Constantin JM, Devlin JW, Ely EW, Fraser GL, G\u00e9linas C, et al. Analgesia and sedation in patients with ARDS. Intensive Care Med. 2020;46:2342\u201356.","journal-title":"Intensive Care Med"},{"key":"857_CR34","volume":"2012","author":"CH Vinkers","year":"2012","unstructured":"Vinkers CH, Olivier B. Mechanisms underlying tolerance after long-term benzodiazepine use: a future for subtype-selective GABA(A) receptor modulators? Adv Pharmacol Sci. 2012;2012:416864.","journal-title":"Adv Pharmacol Sci"},{"key":"857_CR35","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1097\/ALN.0000000000004811","volume":"140","author":"R Vellinga","year":"2024","unstructured":"Vellinga R, Koomen JV, Eleveld DJ, St\u00f6hr T, Pesic M, Struys M, et al. Target-controlled infusion of remimazolam in healthy volunteers shows some acute tolerance. Anesthesiology. 2024;140:207\u201319.","journal-title":"Anesthesiology"},{"key":"857_CR36","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1097\/ALN.0000000000003102","volume":"132","author":"A Eisenried","year":"2020","unstructured":"Eisenried A, Sch\u00fcttler J, Lerch M, Ihmsen H, Jeleazcov C. Pharmacokinetics and pharmacodynamics of remimazolam (CNS 7056) after continuous infusion in healthy male volunteers: part II. Pharmacodynamics of electroencephalogram effects. Anesthesiology. 2020;132:652\u201366.","journal-title":"Anesthesiology"},{"key":"857_CR37","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s00540-022-03079-y","volume":"36","author":"K Masui","year":"2022","unstructured":"Masui K, St\u00f6hr T, Pesic M, Tonai T. A population pharmacokinetic model of remimazolam for general anesthesia and consideration of remimazolam dose in clinical practice. J Anesth. 2022;36:493\u2013505.","journal-title":"J Anesth"},{"key":"857_CR38","volume":"44","author":"N Grillot","year":"2025","unstructured":"Grillot N, Vourc\u2019h M, Hourmant Y, Bouras M, Rozec B, Rouhani A, et al. A phase 2 open-label pilot study of remimazolam for sedation in critically ill patients. ACCPM. 2025;44:101510.","journal-title":"ACCPM"},{"key":"857_CR39","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.70130","volume":"13","author":"J Hu","year":"2025","unstructured":"Hu J, Zhao Y, Shao L, Zhang W, Wang H, Liu Y, et al. Pharmacokinetic properties and therapeutic effectiveness of remimazolam in ICU patients with mechanical ventilation: a preliminary study. Pharmacol Res Perspect. 2025;13:e70130.","journal-title":"Pharmacol Res Perspect"},{"key":"857_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1526266","volume":"16","author":"J Chen","year":"2025","unstructured":"Chen J, Wang X, Chen D, Liu X, Peng K, Tang R, et al. Population pharmacokinetic analysis of remimazolam after continuous infusion for sedation in critically ill patients. Front Pharmacol. 2025;16:1526266.","journal-title":"Front Pharmacol"},{"key":"857_CR41","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.bja.2025.02.038","volume":"135","author":"DJ Eleveld","year":"2025","unstructured":"Eleveld DJ, Colin PJ, den Van Berg JP, Koomen JV, Stoehr T, Struys M. Development and analysis of a remimazolam pharmacokinetics and pharmacodynamics model with proposed dosing and concentrations for anaesthesia and sedation. Br J Anaesth. 2025;135:206\u201317.","journal-title":"Br J Anaesth"},{"key":"857_CR42","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1007\/s00540-024-03398-2","volume":"38","author":"S Obara","year":"2024","unstructured":"Obara S, Kamata K, Nakao M, Yamaguchi S, Kiyama S. Recommendation for the practice of total intravenous anesthesia. J Anesth. 2024;38:738\u201346.","journal-title":"J Anesth"}],"container-title":["Journal of Intensive Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40560-026-00857-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40560-026-00857-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40560-026-00857-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T17:10:16Z","timestamp":1771434616000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40560-026-00857-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,23]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["857"],"URL":"https:\/\/doi.org\/10.1186\/s40560-026-00857-8","relation":{},"ISSN":["2052-0492"],"issn-type":[{"value":"2052-0492","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,23]]},"assertion":[{"value":"30 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"16"}}